Log In
Print
BCIQ
Print
Print this Print this
 

Anti-PD-L1 (BMS-936559, MDX-1105)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHuman mAb against PD-L1
Molecular Target Programmed cell death 1 ligand 1 (CD274 molecule) (PD-L1) (B7-H1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today